AHF Urges Vaccine Equity as Mpox Cases Surge in Sierra Leone
Sierra Leone accounted for 41% of the continent's cases as of June 24. Since January 10, the country has recorded 4,350 confirmed cases and 28 deaths. Since late March, only 40,000 people had been vaccinated, many of them frontline healthcare workers and high-risk groups, including people living with HIV. With limited isolation capacity and just two contacts traced per confirmed case, the response is stretched thin. According to the Africa CDC, more than 6.4 million vaccine doses are needed across the region to meet demand, yet access remains restricted by high prices and limited supply.
'We commend Sierra Leone's rapid response in collaboration with the Africa CDC, but they—and the entire region—should not have to fight this outbreak alone,' said Dr. Penninah Iutung, AHF Africa Bureau Chief. 'We urge high-income countries to immediately release vaccine doses from their reserves and support equitable access to prevention tools. We also call on Bavarian Nordic to reduce the cost of its Jynneos mpox vaccine and to share technology and production knowledge with qualified African manufacturers. Without affordable regional production and greater global collaboration, the world remains vulnerable to preventable infectious disease outbreaks like mpox.'
The outbreak extends far beyond Sierra Leone, with the Democratic Republic of the Congo remaining as the epicenter of Africa's outbreak. Uganda, Burundi, Malawi, and over a dozen other countries have also reported significant case numbers. The World Health Organization continues to classify mpox as a Public Health Emergency of International Concern, citing surging cases, ongoing vaccine shortages, and rising instability.
AIDS Healthcare Foundation (AHF), the largest global AIDS organization, currently provides medical care and/or services to over 2.4 million clients in 48 countries worldwide in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region and Europe. To learn more about AHF, please visit our website: www.aidshealth.org, find us on Facebook: www.facebook.com/aidshealth and follow us on Twitter: @aidshealthcare and Instagram: @aidshealthcare
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hill
4 hours ago
- The Hill
USAID cuts could result in 14M additional deaths: Research
A study published Monday found that the closure of the U.S. Agency for International Development (USAID) could result in more than 14 million additional deaths globally by 2030, including 4.5 million deaths of children younger than 5 years. The findings were released hours before Secretary of State Marco Rubio said the agency would officially shut down following President Trump's executive order earlier this year aiming to dismantle the agency. Many of the deaths are expected to occur in the African countries of Nigeria and Uganda due to the loss of funding for maternal and child health aid, in addition to epidemic and emerging disease surveillance. Researchers found that those two countries would contribute to 107,000 additional deaths globally in just one year of a disrupted malaria-control supply chain. The end of USAID pulls funding from non-governmental organizations including the UN World Food Programme, which closed its southern Africa office, placing 27 million people at risk of hunger amid the country's worst drought in decades, the study says. Former Presidents Obama and Bush have been critical of the Trump administration for the USAID closure, which also threatens to scale back America's role in the global fight against HIV and AIDS. 'Gutting USAID is a travesty, and it's a tragedy. Because it's some of the most important work happening anywhere in the world,' Obama said, according to The Associated Press. Rubio on Tuesday defended the shuttering of USAID, arguing the agency's objectives were often left unmet. 'Development objectives have rarely been met, instability has often worsened, and anti-American sentiment has only grown,' Rubio wrote in a blog post on Tuesday. 'This era of government-sanctioned inefficiency has officially come to an end.' The Monday study found that USAID-supported efforts have helped to prevent more than 91 million deaths across all age groups, including 30 million deaths among children. It said high levels of USAID funding were associated with a 15 percent reduction in mortality across all ages, a 65 percent reduction in mortality from HIV/AIDS, a 51 percent reduction from malaria, and a 50 percent reduction from neglected tropical diseases. In 2022, USAID was responsible for more than half of nutrition interventions, food distribution and agricultural interventions globally. 'Therefore, the impact of USAID on health and mortality reduction extends beyond its direct funding of health programmes and interventions,' the study's authors wrote. 'In particular, USAID's support for poverty alleviation, education, and water and sanitation interventions—among many others—might have had a substantial effect on health outcomes, also considering the broader spillover effects these interventions can have on entire communities,' it added. 'Indeed, poverty alleviation interventions alone have demonstrated important effects on reducing both adult and child mortality.' The research was funded by the Spanish Ministry of Science and Innovation, UK Medical Research Council and EU Horizon Europe.
Time Business News
5 hours ago
- Time Business News
How Cognitive Behavioral Therapy Is Used in Evidence-Based Addiction Recovery Treatment
Understanding Evidence-Based Addiction Recovery Evidence-based addiction recovery refers to treatment methods that have been scientifically validated through rigorous clinical research. This approach prioritizes interventions that consistently produce measurable, positive outcomes for individuals struggling with substance use disorders. In a field often clouded by anecdotal practices, evidence-based care introduces a dependable structure to rehabilitation. It emphasizes repeatable strategies rather than one-size-fits-all solutions. Clinicians rely on data, not guesswork, to guide individuals through complex psychological and physiological terrain. As addiction is multifactorial in nature, this methodology embraces both behavioral science and medical precision to foster enduring recovery. Pathways to Recovery and Renewal Overcoming substance dependence involves a multifaceted approach that addresses the physical, emotional, and psychological aspects of the individual. Support often begins with medically supervised detoxification, followed by therapy and counseling to explore the root causes of substance use. Drug Addiction Treatment offers personalized strategies, including behavioral therapies and, when necessary, medications to reduce cravings and withdrawal symptoms. Group therapy and support networks also play a crucial role in maintaining long-term recovery. Lasting change requires ongoing commitment, but with the right resources and support systems, individuals can reclaim control and move toward a healthier, more fulfilling future. The Role of Medication-Assisted Treatment (MAT) Medication-Assisted Treatment, or MAT, employs FDA-approved medications in conjunction with behavioral therapies to treat substance use disorders. Rather than substituting one dependency for another, MAT stabilizes neurochemical imbalances caused by prolonged drug or alcohol misuse. For opioid addiction, buprenorphine, methadone, and naltrexone are often used; alcohol dependency might be treated with disulfiram or acamprosate. These medications act on the brain's reward circuitry, minimizing cravings and withdrawal symptoms while creating space for cognitive restructuring. MAT reorients individuals from constant chemical compulsion toward regulated functioning and increased treatment engagement. MAT's Impact on Long-Term Sobriety The true potency of MAT lies in its ability to diminish the likelihood of relapse, particularly during the early, volatile stages of recovery. By buffering the physical torment of detox and reducing drug-seeking impulses, MAT enables individuals to participate fully in therapeutic processes. Sustained medication use has shown to decrease illicit opioid use, HIV transmission, and mortality. Long-term sobriety requires both physiological and psychological repair, and MAT offers a scaffolding upon which patients can rebuild cognitive clarity, emotional equilibrium, and behavioral consistency. Recovery becomes less about enduring abstinence and more about reclaiming autonomy. Introducing Cognitive Behavioral Therapy (CBT) Cognitive Behavioral Therapy is a structured, short-term psychotherapy that explores the intricate relationships between thoughts, emotions, and behaviors. Rooted in cognitive theory, CBT identifies distorted thinking patterns—such as catastrophizing or black-and-white thinking—that fuel addictive behavior. In the context of substance use disorders, CBT uncovers the triggers and mental habits that perpetuate cravings and use. The approach isn't abstract; it's methodical, collaborative, and deeply practical. Clients learn to reframe maladaptive thoughts and develop actionable coping strategies, cultivating psychological flexibility and reducing vulnerability to relapse. How CBT Integrates with MAT in Dual-Faceted Treatment When fused with MAT, CBT forms a dynamic, dual-faceted recovery model. Medication addresses the biological entrapments of addiction, while CBT dismantles the psychological scaffolds that uphold it. Together, they disrupt the feedback loop of craving, usage, and guilt. A patient stabilized on buprenorphine, for instance, is far more capable of engaging in CBT sessions that explore emotional trauma or interpersonal dysfunction. This synergistic approach not only accelerates the healing process but also equips individuals with cognitive tools to manage future stressors without returning to substances. The integration is more than parallel treatment—it is a harmonized strategy. Benefits of Combining CBT with Medication-Assisted Treatment The fusion of CBT and MAT transcends symptom control—it catalyzes holistic transformation. While MAT quiets the body's chemical scream for substances, CBT empowers individuals to interrogate and reprogram the mental scripts that drive destructive behavior. Patients build emotional resilience, learn delayed gratification, and practice impulse control. Over time, they reconstruct identities no longer tethered to addiction but anchored in accountability and purpose. This dual-modality approach fosters a robust recovery environment where behavioral stability and neurochemical balance support each other like intertwined roots of a growing tree. Challenges and Considerations in Implementation Despite its efficacy, integrating MAT and CBT is not without hurdles. Societal stigma often casts MAT as a lesser form of sobriety, deterring some from even attempting it. Access to licensed prescribers and trained therapists can be scarce, especially in rural or underserved communities. Compliance also remains an issue, particularly when mental illness coexists with substance use—dual diagnoses complicate both medication efficacy and cognitive receptivity. Additionally, external triggers—stress, poverty, or social instability—can undermine even the most well-structured plans. Treatment must remain adaptive, responsive, and relentlessly compassionate. Conclusion: A Pathway to Sustainable Recovery The future of addiction recovery lies in integrated, evidence-backed care that respects the interplay of body and mind. By marrying the neurological support of Medication-Assisted Treatment with the psychological insight of Cognitive Behavioral Therapy, treatment becomes not just survivable but transformative. Individuals are no longer passive recipients of care but active architects of their recovery journeys. In this union of science and soul, long-term sobriety is not merely a goal—it becomes a lived reality defined by resilience, clarity, and renewal. TIME BUSINESS NEWS
6 hours ago
HHS layoffs were likely unlawful and must be halted, US judge says
PROVIDENCE, R.I. -- A federal judge has ruled that recent mass layoffs at the U.S. Department of Health and Human Services were likely unlawful and ordered the Trump administration to halt plans to downsize and reorganize the nation's health workforce. U.S. District Judge Melissa DuBose granted the preliminary injunction sought by a coalition of attorneys general from 19 states and the District of Columbia in a lawsuit filed in early May. DuBose said the states had shown 'irreparable harm,' from the cuts and were likely to prevail in their claims that 'HHS's action was both arbitrary and capricious as well as contrary to law.' 'The executive branch does not have the authority to order, organize, or implement wholesale changes to the structure and function of the agencies created by Congress,' DuBose wrote in a 58-page order handed down in U.S. district court in Providence. Her order blocks the Trump administration from finalizing layoffs announced in March or issuing any further firings. HHS is directed to file a status report by July 11. The ruling applies to terminated employees in four different divisions of HHS: the U.S. Centers for Disease Control and Prevention; the Center for Tobacco Products within the Food and Drug Administration; the Office of Head Start within the Administration for Children and Families and employees of regional offices who work on Head Start matters; and the Office of the Assistant Secretary for Planning and Evaluation. Health Secretary Robert F. Kennedy Jr. eliminated more than 10,000 employees in late March and consolidated 28 agencies to 15. Since then, agencies including the CDC have repeatedly rescinded layoffs affecting hundreds of employees, including in branches that monitor HIV, hepatitis and other diseases. The attorneys general argued that the massive restructuring was arbitrary and outside of the scope of the agency's authority. The lawsuit also says the action decimated essential programs and pushed burdensome costs onto states. 'The intended effect … was the wholesale elimination of many HHS programs that are critical to public health and safety,' the lawsuit argued. The cuts are part of a federal 'Make America Healthy Again' directive to streamline costly agencies and reduce redundancies. Kennedy told senators at a May 14 hearing that there is 'so much chaos and disorganization" at HHS. But the restructuring had eliminated key teams that regulate food safety and drugs, as well as support a wide range of programs for tobacco, HIV prevention and maternal and infant health. Kennedy has since said that because of mistakes, 20% of people fired might be reinstated. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
